Skip to main navigation
Repare Therapeutics
  • Company
    • About Us
    • Leadership
    • Partnering
    • Contact
  • Science
    • Discovery Platform
    • Therapeutic Focus
    • Scientific References
  • Pipeline
    • Development Pipeline
    • Camonsertib ATR Inhibitor
    • RP-6306 PKMYTI Inhibitor
    • Polϴ Inhibitor
  • Clinical Trials
    • Clinical Trials Overview
  • Careers
    • Job Opportunities
    • Our Culture
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Investor Resources
      • Investor FAQs
      • Investor Email Alerts
      • Contact IR
Select Page

Press Releases

Press Releases

Feb 03, 2022
Repare Therapeutics to Participate in Two Upcoming Virtual Investor Conferences
Jan 07, 2022
Repare Therapeutics Provides Corporate Update and Highlights Key Milestones Anticipated in 2022
Jan 05, 2022
Repare Therapeutics Expands Executive Leadership Team with the Appointment of Philip Herman as EVP Commercial & New Product Development
Jan 03, 2022
Repare Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Displaying 11 - 14 of 14
Media & IR Contact
Investor Contact

Kimberly Minarovich
Argot Partners
[email protected]

Media Contact

David Rosen
Argot Partners
[email protected]

Helpful Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
Company
  • About Us
  • Leadership
  • Partnering
  • Contact
Science
  • Discovery Platform
  • Therapeutic Focus
  • Scientific References
Pipeline
  • Development Pipeline
  • Camonsertib ATR Inhibitor
  • RP-6306 PKMYTI Inhibitor
  • Polϴ Inhibitor
Clinical Trials
  • Clinical Trials Overview
Careers
  • Job Opportunities
  • Our Culture
Investors & Media
  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor Resources
Repare Therapeutics logo
© 2022 Repare Therapeutics
  • Privacy Policy
  • Terms of Use
  • Cookie Policy